V-Square Quantitative Management’s Fiserv Inc FISV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$769K Buy
15,688
+2,227
+17% +$124K 0.07% 239
2026
Q1
$751K Sell
13,461
-170
-1% -$10.5K 0.08% 216
2025
Q4
$916K Buy
13,631
+1,421
+12% +$119K 0.1% 174
2025
Q3
$1.57M Buy
12,210
+771
+7% +$110K 0.27% 72
2025
Q2
$1.97M Sell
11,439
-924
-7% -$168K 0.26% 70
2025
Q1
$2.73M Buy
12,363
+666
+6% +$146K 0.4% 45
2024
Q4
$2.4M Sell
11,697
-116
-1% -$23.7K 0.34% 50
2024
Q3
$2.12M Buy
11,813
+249
+2% +$41.1K 0.31% 57
2024
Q2
$1.72M Sell
11,564
-418
-3% -$63.3K 0.28% 58
2024
Q1
$1.91M Buy
11,982
+2,448
+26% +$357K 0.27% 52
2023
Q4
$1.27M Buy
9,534
+2,705
+40% +$332K 0.22% 62
2023
Q3
$771K Buy
6,829
+1,963
+40% +$242K 0.34% 53
2023
Q2
$614K Buy
+4,866
New +$573K 0.45% 46

Other funds holding FISV

V-Square Quantitative Management's FISV Position: Q2 2026 in Review

V-Square Quantitative Management increased its Fiserv Inc (FISV) stake by 17% in Q2 2026, buying an estimated $124K and bringing the position to 15,688 shares worth $769K. The position accounts for 0.07% of the portfolio, ranked #239.

V-Square Quantitative Management first reported a position in FISV in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.73M in Q1 2025. 823 funds tracked by Wall St. Rank hold FISV as of Q2 2026.

  • V-Square Quantitative Management held 15,688 shares of Fiserv Inc worth $769K as of Q2 2026.
  • V-Square Quantitative Management bought 2,227 Fiserv Inc shares in Q2 2026, an estimated $124K.
  • Fiserv Inc made up 0.07% of V-Square Quantitative Management's portfolio in Q2 2026, its #239 holding.
  • V-Square Quantitative Management first reported a position in Fiserv Inc in Q2 2023 and has held it in 13 quarters since.
  • V-Square Quantitative Management's Fiserv Inc position peaked at $2.73M in Q1 2025.
  • 823 funds tracked by Wall St. Rank held Fiserv Inc as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.